![Hardman & Co](https://directorstalk.net/wp-content/uploads/2015/10/Hardman-logo-white.jpg)
Avacta Group Affimer Drug Conjugates a reality
Avacta Group Plc (LON:AVCT) is the proprietary owner of Affimer technology for the development of bio-therapeutics, diagnostic tests and research reagents. Affimers represent a radical alternative to established antibody technology